1. Jing Liao#, Dan-Ni Zeng#, Jin-Zhu Li, Qiao-Min Hua, Chun-Xia Huang, Jing Xu, Chong Wu, Limin
Zheng, Wei-Ping Wen*, Yan Wu*. Type I IFNs Repolarized a CD169+ Macrophage Population with
Anti-tumor Potentials in Hepatocellular Carcinoma. Molecular Therapy. 2022.02, 30(2):632-643 (IF: 12.91)
2. Jing Liao, Yan Luan, Zhenhua Ren, Xiaojuan Liu, Diyuan Xue, Hairong Xu, Zhichen Sun, Kaiting
Yang, Hua Peng*, Yang-Xin Fu*. Converting Lymphoma Cells into Potent Antigen-Presenting Cells for
Interferon-Induced Tumor Regression. Cancer Immunology Research. 2017.07, 5(7): 560-570 (IF: 12.02)
3. Chengzhou Mao#, Shi-Min Zhuang#, Zijin Xia, Zhi-Wen Xiao, Chun-Xia Huang, Wei-Ping Wen,
Qiang Su, Jun Chen*, Jing Liao*. Pan-cancer Analysis of GALNTs Expression Identifies a Prognostic of
GALNTs Feature in Low Grade Glioma. Journal of Leukocyte Biology. 2022.10, 112(4):887-899 (IF: 6.011)
4. Xiaoxue Chen#, Zhechong Zhou#, Chunliu Huang#, Ziliang Zhou, Sisi Kang, Zhaoxia Huang,
Guanmin Jiang, Zhongsi Hong, Qiuyue Chen, Mei Yang, Suhua He, Siqi Liu, Jie Chen, Kenan Li, Xin Li,
Jing Liao*, Jun Chen*, Shoudeng Chen*. Crystal structures of bat and human coronavirus ORF8 protein
Ig-like domain provide insights into the diversity of immune responses. Frontiers in Immunology. 2021.12,
https://doi.org/10.3389/fimmu.2021.807134 (IF: 8.786)
5. Jing Liao#, Jin-Zhu Li#, Jing Xu, Yongquan Xu, Wei-Ping Wen, Limin Zheng, Lian Li. High
S100A9+ Cell Density Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients after Curative
Resection. Aging (Albany NY). 2021.06, 13(12):16367-16380 (IF: 5.955)
6. Jing Liao, Dan-Ni Zeng, Jin-Zhu Li, Qiao-Min Hua, Zhiyu Xiao, Chuanchao He, Kai Mao, Ling-Yan
Zhu, Yifan Chu, Wei-Ping Wen, Limin Zheng, Yan Wu. Targeting Adenosinergic Pathway Enhances the
Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma. Hepatology International. 2020.01,
14(1):80-95 (IF: 9.029)
7. Yifan Chu#, Jing Liao#, Jinqing Li, Yongchun Wang, Xingjuan Yu, Junfeng Wang, Limin Zheng,
Jing Xu*, Lian Li*. CD103+ Tumor-infiltrating Lymphocytes Predict Favorable Prognosis in Patients with
Esophageal Squamous Cell Carcinoma. Journal of Cancer. 2019.08, 10(21):5234-5243 (IF: 4.478)
8. Diyuan Xue#, Benjamin Moon#, Jing Liao, Jingya Guo, Zhuangzhi Zou, Yanfei Han, Shuaishuai
Cao, Yang Wang, Yang-Xin Fu*, Hua Peng*. A tumor-specific pro-IL-12 activates preexisting cytotoxic T
cells to control well-established tumors. Science Immunology. 2022.01, 7(67):eabi6899 (IF: 30.63)
9. Chong Wu#, Jie Lin#, Yulan Weng, Dan-Ni Zeng, Jing Xu, Shufeng Luo, Li Xu, Mingyu Liu,
Qiaomin Hua, Chao-Qun Liu, Jin-Qing Li, Jing Liao, Cheng Sun, Jian Zhou, Min-Shan Chen, Chao Liu,
Zhenhong Guo, Shi-Mei Zhuang, Jin-Hua Huang, Limin Zheng. Myeloid signature reveals immune
contexture and predicts the prognosis of hepatocellular carcinoma. Journal of Clinical Investigation.
2020.09, 130(9):4679-4693 (IF: 19.456)
10. Zhenhua Ren, Jingya Guo, Jing Liao, Yan Luan, Zhida Liu, Zhichen Sun, Xiaojuan Liu, Yong
Liang, Hua Peng*, Yang-Xin Fu*. CTLA-4 Limits Anti-CD20-Mediated Tumor Regression. Clinical Cancer
Research. 2017.01, 23(1): 193-203 (IF: 13.801)
代表性成果: